Intellipharmaceutics International Inc.
IPCIF · OTC
8/31/2023 | 5/31/2023 | 2/28/2023 | 11/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -85.7% | 47.1% | 999.5% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -1,171.5% | 93% | 84.2% | 100% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -2,541.9% | 1.9% | -79.9% | -1,374.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,749.2% | -11.3% | -109% | -2,947% |
| EPS Diluted | -0.057 | -0.002 | -0.011 | -0.026 |
| % Growth | -3,468.8% | 85% | 59.5% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |